The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Psychiatry Research

• Publication date

  2016-07-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2016.04.097PMID 27156027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.

  2015cited by this paper
• Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China

  2014cited by this paper
• Early improvement as a predictor of treatment response and remission in patients with schizophrenia: A pooled, post-hoc analysis from the asenapine development program

  2014cited by this paper
• Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia

  2014cited by this paper
• New approaches to psychiatric diagnostic classification.

  2014cited by this paper
• Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.

  2013cited by this paper
• An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case–control study

  2013cited by this paper
• Predicting a ‘Combined Treatment Outcome’ in Chronic Schizophrenia: The Role of Demographics, Symptomatology, Functioning and Subjective Well-being

  2013cited by this paper
• Early prediction of clinical and functional outcome in schizophrenia.

  2013cited by this paper
• Response trajectories in "real-world" naturalistically treated schizophrenia patients.

  2012cited by this paper
• Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol

  2012cited by this paper
• Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?

  2011cited by this paper
• Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.

  2011cited by this paper
• Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.

  2011cited by this paper
• Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

  2011cited by this paper
• Evidence-based pharmacotherapy of schizophrenia.

  2011cited by this paper
• Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

  2011cited by this paper
• Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time.

  2011cited by this paper
• Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

  2010cited by this paper
• Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.

  2010cited by this paper
• The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

  2010cited by this paper
• Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

  2009cited by this paper
• Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.

  2008cited by this paper
• Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

  2008cited by this paper
• Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

  2007cited by this paper
• The "delayed onset" of antipsychotic action--an idea whose time has come and gone.

  2006cited by this paper
• Time course for antipsychotic treatment response in first-episode schizophrenia.

  2006cited by this paper
• Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

  2005cited by this paper
• Early prediction of antipsychotic response in schizophrenia.

  2003cited by this paper
• Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.

  2003cited by this paper
• Quality of life in schizophrenia: contributions of anxiety and depression.

  2001cited by this paper
• Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

  1999cited by this paper
• Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

  1998cited by this paper
• Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.

  1991cited by this paper

• Bioenergetic markers in cerebrospinal fluid in first-episode psychosis: Are they predictors of early antipsychotic response and 1-year outcomes?

  2025cites this paper
• Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.

  2024cites this paper
• Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial

  2023cites this paper
• Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials

  2022cites this paper
• Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors.

  2022cites this paper
• Homocysteine Levels and Clinical Outcomes in Schizophrenia—A Pilot Randomized Controlled Trial

  2022cites this paper
• Physical health interventions for patients who have experienced a first episode of psychosis: a narrative review

  2020cites this paper
• The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects

  2017cites this paper
• Does early antipsychotic response predict long‐term treatment outcome?

  2017cites this paper
• Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review

  2017cites this paper